(Total Views: 323)
Posted On: 03/15/2018 8:34:15 AM
Post# of 72446
Your scenario would make IPIX billions upon billions in the long run if our pipeline does as well as many think once on the market if we get a 50% royalty for each product and these royalties are extended over 15 yrs which is near the lifetime of each patent.
Revenue stream sales/yr ($
royalties/yr ($ total royalties
Psoriasis 5, 2.5, 37.5
OM 1, .5, 7.5
IBD 5, 2.5, 37.5
Cancer 10, 5, 75.0
Dermatology 8, 4, 60.0
Anti-Immune 4, 2, 30.0
B Polymer Indust. 2, 1, 15.0
Additional (?) 3, 1.5, 22.5
Total $285 Billion
the above shows the potential of the products if they all prove to be the 1st in class products they have shown so far based on the 50% royalty fee over the lifespan of 15 yrs. I believe there are a lot more applications for our products not yet realized so total could only rise. This shows why a total sale of the company today for $10B or so IMO is ridiculous. In fact, I see $30B today a great deal for some BP as it is peanuts compared to what they Should get in return and an absolute steal for what they Could get in return. They have the money now, spend it and keep the lions share or the total share for themselves.
Revenue stream sales/yr ($
royalties/yr ($ total royalties Psoriasis 5, 2.5, 37.5
OM 1, .5, 7.5
IBD 5, 2.5, 37.5
Cancer 10, 5, 75.0
Dermatology 8, 4, 60.0
Anti-Immune 4, 2, 30.0
B Polymer Indust. 2, 1, 15.0
Additional (?) 3, 1.5, 22.5
Total $285 Billion
the above shows the potential of the products if they all prove to be the 1st in class products they have shown so far based on the 50% royalty fee over the lifespan of 15 yrs. I believe there are a lot more applications for our products not yet realized so total could only rise. This shows why a total sale of the company today for $10B or so IMO is ridiculous. In fact, I see $30B today a great deal for some BP as it is peanuts compared to what they Should get in return and an absolute steal for what they Could get in return. They have the money now, spend it and keep the lions share or the total share for themselves.
(1)
(0)
